Global Cardiopulmonary Resuscitation Market Research Report—Forecast till 2027

$4,450$6,250

According to this report, Global Cardiopulmonary Resuscitation Market accounted for USD 1,603.16 Million in 2019 and is anticipated to exhibit a CAGR of 10.50% during the review period of 2020 to 2027.

Clear

Description

Global Cardiopulmonary Resuscitation Market Research Report—Forecast till 2027

Market Overview
According to this report, Global Cardiopulmonary Resuscitation Market accounted for USD 1,603.16 Million in 2019 and is anticipated to exhibit a CAGR of 10.50% during the review period of 2020 to 2027. Cardiopulmonary revival (CPR) is a lifesaving method helpful in numerous crises, including a respiratory failure or close suffocating, in which somebody’s breathing or heartbeat has halted. During a heart failure, due to an inadequate inventory of blood, the heart quits pulsating. In such conditions, blood flow imperative to supporting life can be given by continually packing the heart through an actual power applied to the patient’s chest. This salvage strategy is named cardiopulmonary revival (CPR), which is utilized in crises or conditions to shield the patient from deadly myocardial localized necrosis or cerebrum harm.
Global Cardiopulmonary Resuscitation Market is expected to register significant market growth owing to the rising prevalence of heart and respiratory diseases, rising geriatric population, rise in government initiatives, increasing global incidence of cancer, and increasing product approvals by major players. The market is expected to expand due to the increasing awareness regarding medical devices and key measures taken by government bodies in the adoption of monitoring devices and improving emergency paramedical services.
Market Segmentation
Global Cardiopulmonary Resuscitation Market has been categorized into Product Type, Compressor Type, Application, and End User.
Based on Product Type, the market is segmented into piston CPR devices, load-distributing band (LDB), active compression-decompression (ACD) devices and impedance threshold device, extracorporeal techniques, and invasive perfusion devices, and others. In terms of compressor type, the market is segmented into manual CPR and automatic mechanical CPR.
Based on application type, the global cardiopulmonary resuscitation market is classified into emergency departments, coronary & intensive care units, organ transplant facilities, air medevac units, and EMT rescue units. In terms of end-user, the market is classified into hospitals and clinics, cardiac catheterization laboratories, organ transplant units, and others.
Regional Analysis
Geographically, Global Cardiopulmonary Resuscitation Market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to command the largest market share owing to the increase in the prevalence of lifestyle diseases and heart diseases.
Europe is expected to contribute to the second largest market of the global cardiopulmonary resuscitation owing to the technological advancements, high disposable income, growing geriatric population, and favorable regulatory framework. Asia-Pacific is set to drive the third-largest share of the global market owing to the rising geriatric population, growing chronic diseases, and elevated utilization of medical devices in healthcare.
Major Players
The Key Players in the Global Cardiopulmonary Resuscitation Market are Stryker, Nihon Kohden Corporation, ZOLL Medical Corporation, Koninklijke Philips N.V., Vyaire Medical, Inc., General Electric Company, CPR Medical Devices, Inc., Michigan Instruments, Corpuls, SCHILLER, and Medtronic.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 17

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS 20

3 RESEARCH METHODOLOGY
3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 27

3.8 VALIDATION 28

4 MARKET DYNAMICS
4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF HEART AND RESPIRATORY DISEASES 30

4.2.2 RISING GERIATRIC POPULATION 30

4.2.3 RISE IN GOVERNMENT INITIATIVES 31

4.3 RESTRAINTS 32

4.3.1 INEFFICIENCY OF MANUAL CPR DEVICES 32

4.4 OPPORTUNITIES 33

4.4.1 AUTOMATED CPR DEVICES 33

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 34

5.1.1 R&D AND DESIGNING 35

5.1.2 MANUFACTURING 35

5.1.3 DISTRIBUTION 35

5.1.4 MARKETING & SALES 35

5.1.1 POST-SALES MONITORING 35

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 37

5.2.4 THREAT OF SUBSTITUTES 37

5.2.5 INTENSITY OF RIVALRY 37

6 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW 38

6.2 PISTON CPR DEVICES 40

6.3 LOAD-DISTRIBUTING BAND (LDB) 41

6.4 ACTIVE COMPRESSION-DECOMPRESSION AND IMPEDANCE THRESHOLD DEVICE (ACD + ITD) 42

6.5 EXTRACORPOREAL TECHNIQUES AND INVASIVE PERFUSION DEVICES 43

6.6 OTHERS 43

7 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY COMPRESSOR TYPE
7.1 OVERVIEW 45

7.2 AUTOMATIC MECHANICAL CPR 46

7.2.1 BATTERY DRIVEN 47

7.2.2 PNEUMATIC DRIVEN 48

7.2.3 MECHANICALLY ACTUATED AND BATTERY DRIVEN 48

7.3 MANUAL CPR 48

8 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY APPLICATION
8.1 OVERVIEW 50

8.2 EMT RESCUE UNITS 51

8.3 CORONARY & INTENSIVE CARE UNITS 52

8.4 EMERGENCY DEPARTMENTS 53

8.5 ORGAN TRANSPLANT FACILITIES 53

8.6 AIR MEDEVAC UNITS 54

8.7 OTHERS 55

9 GLOBAL CARDIOPULMONARY RESUSCITATION MARKET, BY END USER
9.1 OVERVIEW 56

9.2 HOSPITAL & CLINIC 57

9.3 CARDIAC CATHETERIZATION LABORATORIES 58

9.4 ORGAN TRANSPLANT UNIT 58

9.5 OTHERS 59

10 GLOBAL CARDIOPULMONARY RESUSCITATIONMARKET, BY REGION
10.1 OVERVIEW 60

10.2 AMERICAS 61

10.2.1 NORTH AMERICA 64

10.2.1.1 US 67

10.2.1.2 CANADA 69

10.2.2 LATIN AMERICA 71

10.3 EUROPE 73

10.3.1 WESTERN EUROPE 76

10.3.1.1 GERMANY 80

10.3.1.2 UK 82

10.3.1.3 SPAIN 84

10.3.1.4 ITALY 86

10.3.1.5 FRANCE 88

10.3.1.6 REST OF WESTERN EUROPE 90

10.3.2 EASTERN EUROPE 92

10.4 ASIA-PACIFIC 94

10.4.1 CHINA 98

10.4.2 JAPAN 100

10.4.3 INDIA 102

10.4.4 AUSTRALIA 104

10.4.5 SOUTH KOREA 106

10.4.6 REST OF ASIA-PACIFIC 108

10.5 MIDDLE EAST & AFRICA 110

10.5.1 MIDDLE EAST 113

10.5.2 AFRICA 115

11 COMPETITIVE LANDSCAPE: GLOBAL CARDIOPULMONARY RESUSCITATION MARKET
11.1 OVERVIEW 118

11.2 MARKET RANKING ANALYSIS 118

11.3 COMPETITIVE BENCHMARKING 119

11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL CARDIOPULMONARY RESUSCITATION MARKET 120

11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 121

11.6 KEY DEVELOPMENTS AND GROWTH STRATEGIES 121

11.6.1 EXPANSIONS 122

11.6.2 ACQUISITIONS 122

11.6.3 PRODUCT APPROVALS/LAUNCHES 123

11.7 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 123

11.7.1 SALES & OPERATING PROFIT MARGIN 123

11.7.2 R&D EXPENDITURE 124

12 COMPANY PROFILES
12.1 ZOLL MEDICAL CORPORATION 125

12.1.1 COMPANY OVERVIEW 125

12.1.2 FINANCIAL OVERVIEW 126

12.1.3 PRODUCTS/SERVICES OFFERED 126

12.1.4 KEY DEVELOPMENTS 127

12.1.5 SWOT ANALYSIS 127

12.1.6 KEY STRATEGIES 127

12.2 STRYKER 128

12.2.1 COMPANY OVERVIEW 128

12.2.2 FINANCIAL OVERVIEW 128

12.2.3 PRODUCTS/SERVICES OFFERED 129

12.2.4 KEY DEVELOPMENTS 129

12.2.5 SWOT ANALYSIS 130

12.2.6 KEY STRATEGIES 130

12.3 NIHON KOHDEN 131

12.3.1 COMPANY OVERVIEW 131

12.3.2 FINANCIAL OVERVIEW 131

12.3.3 PRODUCTS/SERVICES OFFERED 132

12.3.4 KEY DEVELOPMENTS 132

12.3.5 SWOT ANALYSIS 133

12.3.6 KEY STRATEGIES 133

12.4 KONINKLIJKE PHILIPS N.V. 134

12.4.1 COMPANY OVERVIEW 134

12.4.2 FINANCIAL OVERVIEW 135

12.4.3 PRODUCTS/SERVICES OFFERED 135

12.4.4 KEY DEVELOPMENTS 135

12.4.5 SWOT ANALYSIS 136

12.4.6 KEY STRATEGIES 136

12.5 GE HEALTHCARE 137

12.5.1 COMPANY OVERVIEW 137

12.5.2 FINANCIAL OVERVIEW 137

12.5.3 PRODUCTS/SERVICES OFFERED 138

12.5.4 KEY DEVELOPMENTS 138

12.5.5 SWOT ANALYSIS 138

12.5.6 KEY STRATEGIES 138

12.6 VYAIRE MEDICAL, INC. 139

12.6.1 COMPANY OVERVIEW 139

12.6.2 FINANCIAL OVERVIEW 139

12.6.3 PRODUCTS/SERVICES OFFERED 139

12.6.4 KEY DEVELOPMENTS 139

12.6.5 SWOT ANALYSIS 140

12.6.6 KEY STRATEGIES 140

12.7 CPR MEDICAL DEVICES, INC. 141

12.7.1 COMPANY OVERVIEW 141

12.7.2 FINANCIAL OVERVIEW 141

12.7.3 PRODUCTS/SERVICES OFFERED 141

12.7.4 KEY DEVELOPMENTS 141

12.7.5 SWOT ANALYSIS 142

12.7.6 KEY STRATEGIES 142

12.8 MICHIGAN INSTRUMENTS 143

12.8.1 COMPANY OVERVIEW 143

12.8.2 FINANCIAL OVERVIEW 143

12.8.3 PRODUCTS/SERVICES OFFERED 143

12.8.4 KEY DEVELOPMENTS 143

12.8.5 SWOT ANALYSIS 144

12.8.6 KEY STRATEGIES 144

12.9 CORPULS 145

12.9.1 COMPANY OVERVIEW 145

12.9.2 FINANCIAL OVERVIEW 145

12.9.3 PRODUCTS/SERVICES OFFERED 145

12.9.4 KEY DEVELOPMENTS 145

12.9.5 SWOT ANALYSIS 146

12.9.6 KEY STRATEGIES 146

12.10 SCHILLER 147

12.10.1 COMPANY OVERVIEW 147

12.10.2 FINANCIAL OVERVIEW 147

12.10.3 PRODUCTS/SERVICES OFFERED 147

12.10.4 KEY DEVELOPMENTS 147

12.10.5 SWOT ANALYSIS 148

12.10.6 KEY STRATEGIES 148

12.11 MEDTRONIC 149

12.11.1 COMPANY OVERVIEW 149

12.11.2 FINANCIAL OVERVIEW 150

12.11.3 PRODUCTS/SERVICES OFFERED 150

12.11.4 KEY DEVELOPMENTS 150

12.11.5 SWOT ANALYSIS 151

12.11.6 KEY STRATEGIES 151

13 APPENDIX
13.1 REFERENCES 152

13.2 RELATED REPORTS 152